| Daniel Jonathan Ratcliff, MD | |
|
3705 Medical Pkwy, Suite 310, Austin, TX 78705-1019 | |
| (512) 380-4050 | |
| (512) 380-4092 |
| Full Name | Daniel Jonathan Ratcliff |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 28 Years |
| Location | 3705 Medical Pkwy, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477640357 | NPI | - | NPPES |
| 189307501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2003-0093 (New Mexico) | Secondary |
| 207Y00000X | Otolaryngology | K2989 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Ent Associates | 0345345419 | 5 |
News Archive
The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States, assert Daniel J. Gage, Assistant Director and Alison R. Perencevich, Legislative Assistant, at the American Academy of Pediatrics' Department of Federal Affairs.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Brain metastases are common secondary complications of other types of cancer, particularly lung, breast and skin cancer. The body's own immune response in the brain is rendered powerless in the fight against these metastases by inflammatory reactions. Researchers at the MedUni Vienna have now, for the first time, precisely characterised the brain's immune response to infiltrating metastases. This could pave the way to the development of new, less aggressive treatment options.
A new genetic analysis of more than 12,000 individuals has found that a decrease in low density lipoprotein (LDL) cholesterol, of as little as 15 percent, sustained over the long term can dramatically reduce the risk of coronary heart disease.
› Verified 3 days ago
| Entity Name | Austin Ent Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891840575 PECOS PAC ID: 0345345419 Enrollment ID: O20070418000241 |
News Archive
The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States, assert Daniel J. Gage, Assistant Director and Alison R. Perencevich, Legislative Assistant, at the American Academy of Pediatrics' Department of Federal Affairs.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Brain metastases are common secondary complications of other types of cancer, particularly lung, breast and skin cancer. The body's own immune response in the brain is rendered powerless in the fight against these metastases by inflammatory reactions. Researchers at the MedUni Vienna have now, for the first time, precisely characterised the brain's immune response to infiltrating metastases. This could pave the way to the development of new, less aggressive treatment options.
A new genetic analysis of more than 12,000 individuals has found that a decrease in low density lipoprotein (LDL) cholesterol, of as little as 15 percent, sustained over the long term can dramatically reduce the risk of coronary heart disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Jonathan Ratcliff, MD 3705 Medical Pkwy, Suite 310, Austin, TX 78705-1019 Ph: (512) 380-4050 | Daniel Jonathan Ratcliff, MD 3705 Medical Pkwy, Suite 310, Austin, TX 78705-1019 Ph: (512) 380-4050 |
News Archive
The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States, assert Daniel J. Gage, Assistant Director and Alison R. Perencevich, Legislative Assistant, at the American Academy of Pediatrics' Department of Federal Affairs.
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Brain metastases are common secondary complications of other types of cancer, particularly lung, breast and skin cancer. The body's own immune response in the brain is rendered powerless in the fight against these metastases by inflammatory reactions. Researchers at the MedUni Vienna have now, for the first time, precisely characterised the brain's immune response to infiltrating metastases. This could pave the way to the development of new, less aggressive treatment options.
A new genetic analysis of more than 12,000 individuals has found that a decrease in low density lipoprotein (LDL) cholesterol, of as little as 15 percent, sustained over the long term can dramatically reduce the risk of coronary heart disease.
› Verified 3 days ago
Robert A. Williamson Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6811 Austin Center Blvd, Suite 300, Austin, TX 78731 Phone: 512-346-8888 Fax: 512-406-7321 | |
Dr. Jeffrey S Zapalac, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 310, Austin, TX 78705 Phone: 512-458-6391 Fax: 512-390-4091 | |
Dr. Joel William Jones, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 9835 N Lake Creek Pkwy, Austin, TX 78717 Phone: 832-822-0629 | |
Dr. Tibor Ruff, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 40 N Interstate 35 Apt 9d1, Austin, TX 78701 Phone: 512-947-4612 | |
James R Eskew, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4315 James Casey St, Suite 300, Austin, TX 78745 Phone: 512-444-7944 Fax: 512-444-7946 | |
Kent P Jones, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6811 Austin Center Blvd # 300, Austin, TX 78731 Phone: 512-346-8888 Fax: 512-344-0340 | |
David Crockett Teller, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7901 Metropolis Dr, Austin, TX 78744 Phone: 512-823-4880 Fax: 512-823-4155 |